Literature DB >> 1970073

Ifosfamide in paediatric oncology: tried but not tested?

P J Shaw1, T Eden.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1970073     DOI: 10.1016/0140-6736(90)91076-m

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  High technology drugs for cancer: the decision process for adding to a formulary.

Authors:  J L Glennie; D M Woloschuk; K W Hall
Journal:  Pharmacoeconomics       Date:  1993-12       Impact factor: 4.981

2.  Ifosfamide nephrotoxicity in paediatric cancer patients.

Authors:  M S Ashraf; J Brady; F Breatnach; P F Deasy; A O'Meara
Journal:  Eur J Pediatr       Date:  1994-02       Impact factor: 3.183

3.  Progressive renal toxicity due to ifosfamide.

Authors:  D Heney; J Wheeldon; P Rushworth; C Chapman; I J Lewis; C C Bailey
Journal:  Arch Dis Child       Date:  1991-08       Impact factor: 3.791

4.  Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children's Cancer Study Group.

Authors:  R Skinner; S J Cotterill; M C Stevens
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.